Nanomedicine: Nanotechnology, Biology and Medicine
Volume 1, Issue 1 , Pages 85-90 , March 2005

Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release

  • Amol J. Thote, PhD
    • ,
  • Ram B. Gupta, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Chemical Engineering, Auburn University, Auburn, AL 36849-5127.

Received 23 September 2004 ,Accepted 23 December 2004.

References 

  1. Ul-Ain Q, Sharma S, Khuller GK. Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis. Antimicrob Agents Chemother. 2003;47:3005–3007
  2. Shalaby WSW, Jackson R, Blevins WE, Park K. Synthesis of enzyme-digestible, interpenetrating hydrogel networks for long-term oral drug delivery. Polymer Preprints (American Chemical Society Division of Polymer Chemistry). 1992;33:470–471
  3. Karande P, Jain A, Mitragotri S. Discovery of transdermal penetration enhancers by high-throughput screening. Nature Biotechnol. 2004;22:192–197
  4. Cormier MJN, Trautman JC, Kim HL, Samiee AP, Neukermans AP, Edwards BP, et al. Skin treatment apparatus for sustained transdermal drug delivery. PCT Int Appl. 2001;
  5. Johnson OL, Herbert P. Long-acting protein formulations - prolease technology. Drugs Pharm Sci. 2003;126:671–677
  6. Bodmeier R, McGinity JW. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique I: methods and morphology. J Microencapsulation. 1987;4:279–288
  7. Herrmann J, Bodmeier R. Biodegradable, somatostatin acetate-containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods. Eur J Pharm Biopharm. 1998;45:75–82
  8. Viswanathan NB, Thomas PA, Pandit JK, Kulkarni MG, Mashelkar RA. Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique. J Controlled Release. 1999;58:9–20
  9. McGee JP, Davis SS, O'Hagan DT. Zero order release of protein from poly(DL-lactide-co-glycolide) microparticles prepared using a modified phase separation technique. J Controlled Release. 1995;34:77–86
  10. Iwata M, Tanaka T, Nakamura Y, McGinity JW. Selection of the solvent system for the preparation of poly(D,L-lactic acid-glycolic acid) microspheres containing tumor necrosis factor-alpha (TNF-α). Int J Pharm. 1998;160:145–156
  11. Iwata M, Nakamura Y, McGinity JW. Particle size and loading efficiency of poly(D,L-lactic-coglycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods. J Microencapsulation. 1999;16:49–58
  12. Mandal TK. Evaluation of a novel phase separation technique for the encapsulation of water-soluble drugs in biodegradable polymer. Drug Dev Ind Pharm. 1998;24:623–629
  13. Jiang W, Schwendeman SP. Formaldehyde-mediated aggregation of protein antigens: comparison of untreated and formalinized model antigens. Biotechnol Bioeng. 2000;70:507–517
  14. Schwendeman SP. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit Rev Ther Drug Carrier Syst. 2002;19:73–98
  15. Chattopadhyay P, Gupta RB. Production of antibiotic nanoparticles using supercritical CO2 as antisolvent with enhanced mass transfer. Ind Eng Chem Res. 2001;40:3530–3539
  16. Carrasquillo KG, Stanley AM, Aponte-Carro JC, De JP, Costantino HR, Bosques C, et al. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J Controlled Release. 2001;76:199–208
  17. Johnson OL, Jaworowicz W, Cleland JL, Bailey L, Charnis M, Duenas E, et al. The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm Res. 1997;14:730–735
  18. Ellis EJ, Ellis JY. Controlled drug delivery systems containing acrylic polypropylene glycol polymers. PCT Int Appl 2003, [WO 2003013477].
  19. Baeyens V, Kaltsatos V, Boisrame B, Varesio E, Veuthey J-L, Fathi M, et al. Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections. J Controlled Release. 1998;52:215–220
  20. Sankaram M. Biodegradable compositions for the controlled release of encapsulated substances. PCT Int Appl 2000, [WO 2000003660].
  21. Costantino HR, Johnson OL, Zale SE. Relationship between encapsulated drug particle size and initial release of recombinant human growth hormone from biodegradable microspheres. J Pharm Sci. 2004;93:2624–2634
  22. Costantino HR, Firouzabadian L, Wu C, Carrasquillo KG, Griebenow K, et al. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J Pharm Sci. 2002;91:388–395
  23. Sah H. Protein behavior at the water/methylene chloride interface. J Pharm Sci. 1999;88:1320–1325
  24. Sah H. Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. PDA J Pharm Sci Technol. 1999;53:3–10
  25. van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res. 2000;17:1159–1167
  26. Gupta RB, Chattopadhyay P. Method of forming nanoparticles and microparticles of controllable size using supercritical fluids and ultrasound. US Patent 6,620,351, 2003.
  27. Iwata M, Tanaka T, Nakamura Y, McGinity JW. Selection of the solvent system for the preparation of poly(D,L-lactic-co-glycolic acid) microspheres containing tumor necrosis factor-alpha (TNF-α). Int J Pharm. 1998;160:145–156
  28. Iwata M, Nakamura Y, McGinity JW. Particle size and loading efficiency of poly(D,L-lactic-co-glycolic acid) multiphase microspheres containing water soluble substances prepared by the hydrous and anhydrous solvent evaporation methods. J Microencapsulation. 1999;16:49–58
  29. Thote AJ, Chappell JT, Kumar R, Gupta RB. Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs. Drug Dev Ind Pharm. 2005;1:43–57
  30. Bempong DK, Adkins RE, Lindauer RF, White PA, Mirza T. Development of a dissolution method for levothyroxine sodium tablets. Pharmacopeial Forum. 1999;25:
  31. Chattopadhyay P, Gupta RB. Protein nanoparticles formation by supercritical antisolvent with enhanced mass transfer. AIChE J. 2002;48:235–244
  32. Ruiz JM, Tissier B, Benoit JP. Microencapsulation of peptide: A study of phase separation of poly(D,L-lactic acid-co-glycolic acid) copolymers 50/50 by silicon oil. Int J Pharm. 1989;49:69–77
  33. Stassen S, Nihant N, Martin V, Grandfils C, Jerome R, Teyssie P. Microencapsulation by coacervation of poly(lactide-co-glycolide). I. Physicochemical characteristics of the phase separation process. Polymer. 1994;35:777–785
  34. Nihant N, Stassen S, Grandfils C, Jerome R, Teyssie P. Microencapsulation by coacervation of poly(lactide-co-glycolide), II: Encapsulation of a dispersed aqueous phase. Polymer Int. 1993;32:171–176
  35. Nihant N, Grandfils C, Jerome R, Teyssie P. Microencapsulation by coacervation of poly(lactide-co-glycolide), IV: Effect of the processing parameters on coacervation and encapsulation. J Controlled Release. 1995;35:117–125

PII: S1549-9634(05)00011-0

doi: 10.1016/j.nano.2004.12.001

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 1, Issue 1 , Pages 85-90 , March 2005

Article Tools

* Image Usage & Resolution